)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
The committee flagged severe specialist shortages and proposed that trained general physicians supervise dialysis units as an interim measure while a national CKD strategy is developed
The regulator granted registered projects four additional months after the Centre classified the West Asia conflict as a force majeure event disrupting construction supply chains.
The panel has recommended that basic hospital room tariffs should not exceed average room rates at three-star hotels in the peripheral area or vicinity of the facility
States and municipal authorities need to unlock land, ease development norms and improve access to finance to lower project costs and attract private investment
Medical device manufacturers call draft drugs, medical devices and cosmetics bill pharma-centric, misaligned with global medtech norms
The consultations, scheduled for August 28, follow new ICMR guidelines proposing that a single Ethics Committee review all participating sites in multicentre research
The Gurugram-based developer is eyeing low-rise, large-format projects outside Delhi-NCR while targeting launches worth Rs 15,000 crore and sales of Rs 10,000 crore in FY27
No deadline set for policy; non-scheduled drugs account for 82% of market, average channel markup on common dosage forms is 43%
The market recorded sales of Rs 23,193 crore in July, with cardiac and anti-diabetic therapies posting double-digit growth and four leading segments accounting for 46.6 per cent
The seven-year lease at Casagrand Industrial Park comes as India's logistics and industrial real estate sector records its strongest first-half leasing performance
KKR will acquire Medicover India's hospital business in a €1.2 billion deal, strengthening its healthcare portfolio and expanding its footprint across southern and western India
The government think tank has recommended a national caregiver policy, a dedicated council and a qualification framework to build a skilled workforce and tap rising domestic and global demand.
Developer says weak first-quarter bookings reflected deferred launches and expects projects in Gurugram, Mumbai and Goa to help achieve its FY27 sales target.
Legal experts said that it should not be construed as permitting developers to increase prices for units already sold
Realty major reports a 4% rise in net profit despite a sharp fall in revenue, with deferred project launches weighing on sales bookings during the June quarter
India's AI data centre boom is driving investments in clean energy, real estate, manufacturing and jobs as global tech giants and conglomerates expand infrastructure
Currently, 250K IVF cycles performed annually; may rise to 400K by 2030
The approval makes Wegovy the first GLP-1 therapy cleared in India for treating adults with non-cirrhotic MASH and moderate-to-advanced liver fibrosis
Improved market access and zero tariffs under the India-UK trade agreement are expected to lift Indian pharmaceutical exports to over $980 million in FY27
The eyewear retailer has signed a nine-year lease for office space at Worldmark 6 in Delhi's Aerocity, with monthly rentals of Rs 1.86 crore and a 15 per cent escalation every three years